Hans Van Vlierberghe
- Hepatology top 0.1%
- Liver Disease and Transplantation 84
- Hepatitis C virus research 65
- Hepatocellular Carcinoma Treatment and Prognosis 49
- Liver Diseases and Immunity 20
- Liver physiology and pathology 19
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 123
- Hepatitis B Virus Studies 45
- Transplantation top 2%
- Surgery top 1%
- Organ Transplantation Techniques and Outcomes 51
- Cell Biology top 2%
- Co-authors
- Isabelle ColleAnja GeertsFemke HeindryckxXavier VerhelstChristophe Van SteenkisteJoris DelangheNico CallewaertRoberto Troisi
- Partner nations
- BelgiumUnited StatesGermany
In The Last Decade
Hans Van Vlierberghe
322 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Hepatology 4.3k
- Epidemiology 3.8k
- Transplantation 203
- Surgery 2.1k
- Cell Biology 638
Countries citing papers authored by Hans Van Vlierberghe
This map shows the geographic impact of Hans Van Vlierberghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Van Vlierberghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Van Vlierberghe more than expected).
Fields of papers citing papers by Hans Van Vlierberghe
This network shows the impact of papers produced by Hans Van Vlierberghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Van Vlierberghe. The network helps show where Hans Van Vlierberghe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans Van Vlierberghe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 9 | |
| 7 | 2021 | 37 | |
| 8 | 2019 | 11 | |
| 9 | 2018 | 4 | |
| 10 | 2018 | 15 | |
| 11 | 2016 | 28 | |
| 12 | 2016 | 2 | |
| 13 | Hepatitis C epidemiology in Belgium. | 2014 | 5 |
| 14 | Treatment of chronic hepatitis C in patients with human immunodeficiency virus (HIV) with weekly peginterferon alpha-2b plus ribavirin: a multi-centred Belgian study. | 2010 | 1 |
| 15 | Effectiveness and tolerability of pegylated interferon alfa-2b in combination with ribavirin for treatment of chronic hepatitis C: the PegIntrust study. | 2010 | 3 |
| 16 | LTx for alcoholic liver disease: a retrospective analysis of recidivism, survival and risk factors predisposing to alcohol relapse | 2010 | 2 |
| 17 | The HCV Serum proteome: A search for fibrosis protein markers | 2008 | 1 |
| 18 | Re-188-HDD/Lipiodol for hepatocellular carcinoma: our experience with the first 100 treatments. | 2006 | 1 |
| 19 | Improvement in liver histology after 3 years of E1 therapeutic vaccination in 23 patients with chronic hepatitis C | 2004 | 2 |
| 20 | 2004 | 46 |
About Hans Van Vlierberghe
Hans Van Vlierberghe is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 332 papers that have together received 8.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (123 papers), Liver Disease and Transplantation (84 papers), Hepatitis C virus research (65 papers), Organ Transplantation Techniques and Outcomes (51 papers), Hepatocellular Carcinoma Treatment and Prognosis (49 papers), Hepatitis B Virus Studies (45 papers), Liver Diseases and Immunity (20 papers) and Liver physiology and pathology (19 papers). The work is most often cited by research in Hepatology (4.3k citations), Epidemiology (3.8k citations) and Transplantation (203 citations). Hans Van Vlierberghe has collaborated with scholars based in Belgium, United States and Germany. Frequent co-authors include Isabelle Colle, Anja Geerts, Femke Heindryckx, Xavier Verhelst, Christophe Van Steenkiste, Joris Delanghe, Nico Callewaert, Roberto Troisi, Lindsey Devisscher and Bernard de Hemptinne.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.